{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:16:22Z","timestamp":1768878982417,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00051\/2020"],"award-info":[{"award-number":["UIDB\/00051\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00051\/2020"],"award-info":[{"award-number":["UIDP\/00051\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n              <jats:title>Background<\/jats:title>\n              <jats:p>Ferritin is commonly used to evaluate iron stores and guide therapeutic decisions regarding intravenous iron supplementation. However, in the context of AHF, inflammation-driven upregulation of ferritin might disrupt its correlation with iron stores, restricting iron bioavailability and potentially amplifying the inflammatory response.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Aim<\/jats:title>\n              <jats:p>This study aims to assess the clinical and prognostic associations of ferritin levels in an AHF cohort and to determine whether the prognostic value of ferritin is influenced by the presence of infection, inflammatory activation, and other markers of iron deficiency.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Methods<\/jats:title>\n              <jats:p>The association between ferritin and clinical outcomes (180\u00a0days) in AHF was evaluated in a cohort of 526 patients from the EDIFICA registry.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Results<\/jats:title>\n              <jats:p>The median ferritin plasma concentration at admission was 180\u00a0pg\/mL. Patients with higher ferritin levels at admission were predominantly men, exhibiting a high prevalence of chronic kidney disease and alcohol consumption, and presenting with lower blood pressure and a higher incidence of clinical infection. Higher ferritin levels were associated with increased risk of the composite of heart failure hospitalization or cardiovascular death (Tertile 2: HR 1.75; 95% CI 1.10\u20132.79; <jats:italic>p<\/jats:italic>\u2009=\u20090.017; Tertile 3: HR 1.79; 95% CI 1.08\u20132.97; <jats:italic>p<\/jats:italic>\u2009=\u20090.025), independently of classical HF prognostic factors, inflammatory and iron-related markers. No significant associations were found between admission serum iron or transferrin saturation tertiles, iron status categories, or guideline-defined iron deficiency (ID) criteria and the primary composite outcome. However, at discharge, patients who met the criteria for defective iron utilization, low iron storage, or guideline-defined ID had a lower risk of the composite endpoint compared to those with normal iron utilization or who did not meet the guideline-defined ID criteria, respectively.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Conclusions<\/jats:title>\n              <jats:p>Elevated ferritin levels are independently associated with poor prognosis in AHF. Low ferritin levels are associated with a favorable outcome and do not carry significant value in identifying ID in this population. <\/jats:p>\n            <\/jats:sec>","DOI":"10.1007\/s00392-024-02535-x","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:22:39Z","timestamp":1726744959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-8538","authenticated-orcid":false,"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"first","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Pimentel","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Isaac","family":"Barroso","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Tiago","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"Adelino F.","family":"Leite-Moreira","sequence":"additional","affiliation":[]},{"suffix":"Jr","given":"Roberto","family":"Roncon-Albuquerque","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fri\u00f5es","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"2535_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"AF Members","year":"2022","unstructured":"Members AF et al (2022) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 24:4\u2013131","journal-title":"Eur J Heart Fail"},{"key":"2535_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.156053","volume":"160","author":"F Vasques-N\u00f3voa","year":"2022","unstructured":"Vasques-N\u00f3voa F et al (2022) Interleukin-6, infection and cardiovascular outcomes in acute heart failure: findings from the EDIFICA registry. Cytokine 160:156053","journal-title":"Cytokine"},{"key":"2535_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-0151-7","volume":"6","author":"M Arrigo","year":"2020","unstructured":"Arrigo M et al (2020) Acute heart failure. Nat Rev Dis Primers 6:1\u201315","journal-title":"Nat Rev Dis Primers"},{"key":"2535_CR4","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ejhf.2879","volume":"25","author":"F Lindberg","year":"2023","unstructured":"Lindberg F et al (2023) Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm Creatinine Measurements collaborative project. Eur J Heart Fail 25:1270\u20131280","journal-title":"Eur J Heart Fail"},{"key":"2535_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2992","author":"P Marques","year":"2023","unstructured":"Marques P et al (2023) Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2992","journal-title":"Eur J Heart Fail"},{"key":"2535_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","volume":"29","author":"KF Kernan","year":"2017","unstructured":"Kernan KF, Carcillo JA (2017) Hyperferritinemia and inflammation. Int Immunol 29:401\u2013409","journal-title":"Int Immunol"},{"key":"2535_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ejhf.611","volume":"19","author":"M Pintalhao","year":"2017","unstructured":"Pintalhao M et al (2017) Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload. Eur J Heart Fail 19:218\u2013225","journal-title":"Eur J Heart Fail"},{"key":"2535_CR8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/jamacardio.2019.1739","volume":"4","author":"N Grote Beverborg","year":"2019","unstructured":"Grote Beverborg N et al (2019) Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies. JAMA Cardiol 4:696\u2013701","journal-title":"JAMA Cardiol"},{"key":"2535_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ejhf.622","volume":"19","author":"IJT Klip","year":"2017","unstructured":"Klip IJT et al (2017) Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community. Eur J Heart Fail 19:348\u2013356","journal-title":"Eur J Heart Fail"},{"key":"2535_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ejhf.701","volume":"19","author":"OM Silvestre","year":"2017","unstructured":"Silvestre OM et al (2017) Ferritin levels and risk of heart failure - the atherosclerosis risk in communities study. Eur J Heart Fail 19:340\u2013347","journal-title":"Eur J Heart Fail"},{"key":"2535_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","volume":"1","author":"JGF Cleland","year":"2016","unstructured":"Cleland JGF et al (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiol 1:539","journal-title":"JAMA Cardiol"},{"key":"2535_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","volume":"79","author":"G Masini","year":"2022","unstructured":"Masini G et al (2022) Criteria for iron deficiency in patients with heart failure. J Am Coll Cardiol 79:341\u2013351","journal-title":"J Am Coll Cardiol"},{"key":"2535_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/hep.22716","volume":"49","author":"RG Ruddell","year":"2009","unstructured":"Ruddell RG et al (2009) Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49:887\u2013900","journal-title":"Hepatology"},{"key":"2535_CR14","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.bbadis.2018.08.030","volume":"1865","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhabyeyev P, Wang S, Oudit GY (2019) Role of iron metabolism in heart failure: from iron deficiency to iron overload. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis 1865:1925\u20131937","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Basis Dis"},{"key":"2535_CR15","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski P et al (2020) Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396:1895\u20131904","journal-title":"Lancet"},{"key":"2535_CR16","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra PR et al (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 400:2199\u20132209","journal-title":"Lancet"},{"key":"2535_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.33935","volume":"4","author":"AA Shah","year":"2021","unstructured":"Shah AA et al (2021) Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis. JAMA Netw Open 4:e2133935","journal-title":"JAMA Netw Open"},{"key":"2535_CR18","doi-asserted-by":"publisher","first-page":"11072","DOI":"10.1038\/s41598-018-29353-2","volume":"8","author":"P Lan","year":"2018","unstructured":"Lan P et al (2018) High serum iron level is associated with increased mortality in patients with sepsis. Sci Rep 8:11072","journal-title":"Sci Rep"},{"key":"2535_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/eurheartj\/ehae086","volume":"45","author":"JGF Cleland","year":"2024","unstructured":"Cleland JGF et al (2024) Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. Eur Heart J 45:1410\u20131426","journal-title":"Eur Heart J"},{"key":"2535_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.124.068883","volume":"150","author":"M Packer","year":"2024","unstructured":"Packer M et al (2024) Redefining iron deficiency in patients with chronic heart failure. Circulation 150:151\u2013161","journal-title":"Circulation"},{"key":"2535_CR21","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1002\/ehf2.14438","volume":"10","author":"FJ Graham","year":"2023","unstructured":"Graham FJ et al (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Fail 10:2826\u20132836","journal-title":"ESC Heart Fail"},{"key":"2535_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ejhf.2036","volume":"23","author":"R Sierpinski","year":"2021","unstructured":"Sierpinski R et al (2021) High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. Eur J Heart Fail 23:919\u2013932","journal-title":"Eur J Heart Fail"},{"key":"2535_CR23","doi-asserted-by":"publisher","first-page":"11911","DOI":"10.1038\/s41598-022-15674-w","volume":"12","author":"M Kang","year":"2022","unstructured":"Kang M et al (2022) Soluble transferrin receptor can predict all-cause mortality regardless of anemia and iron storage status. Sci Rep 12:11911","journal-title":"Sci Rep"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-024-02535-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:23:48Z","timestamp":1726745028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-024-02535-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":23,"alternative-id":["2535"],"URL":"https:\/\/doi.org\/10.1007\/s00392-024-02535-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}